CCL3 and chronic myelogenous leukemia, BCR-ABL1 positive: Conversely, the ablation of CCL3 gene in LICs dramatically inhibited the development of CML and concomitantly reduced recurrence after the cessation of a short-term tyrosine kinase inhibitor treatment.